Sphingosine-1
phosphate (S1P) is a bioactive
sphingolipid with the potential to mobilize Ca2+, to inhibit apoptosis, and to promote mitogenesis.
Sphingosine kinase (SPHK) and S1P were characterized in INS-1
insulinoma cells and isolated rat islets of Langerhans. SPHK activity increased in INS-1 cell homogenates treated with
interleukin-1beta (IL-1beta) or
tumor necrosis factor-alpha (
TNF-alpha), and responses were additive. IL-1beta or
TNF-alpha increased islet SPHK activity within 15 min to 1 h; activity remained elevated after 8 h. SPHK2 was the predominant active
isoform in INS-1 cells; little or no SPHK1 activity was detected.
Cytokines increased endogenous S1P biosynthesis in 32P(i)-prelabeled INS-1 cells, and
cycloheximide inhibited the response after 8 h, suggesting that
protein synthesis mediated the response. There was no [32P]S1P release from cells. Compared with basal values, IL-1beta and
TNF-alpha induced increases in SPHK1a
mRNA levels relative to
18S ribosomal RNA in INS-1 cells within 1 h; relative SPHK2
mRNA levels were unchanged after
cytokine treatment. IL-1beta, but not
TNF-alpha, induced relative SPHK1a
mRNA expression levels within 1 h in islets, whereas SPHK2
mRNA levels were unchanged. Thus, IL-1beta and
TNF-alpha induced an early and sustained increase in SPHK activity in INS-1 cells and isolated islets, suggesting that S1P plays a role in the pathological response of pancreatic beta-cells to
cytokines.